The Braves Reinforce Their Rotation: Chris Sale's Extension to 2028
In a strategic move, the Atlanta Braves have locked down their ace pitcher, Chris Sale, with a multi-year contract extension. This deal, announced on February 24, 2026, ensures Sale's presence in the Braves' rotation until 2028, with an option for 2029. The extension comes as a relief for the team, as Sale's previous contract was set to expire at the end of the 2025 season.
The Braves exercised their $18 million team option for 2026, keeping Sale in the fold for another year. In 2025, Sale demonstrated his prowess, posting a 7-5 record with a 2.58 ERA and an impressive 165 strikeouts. However, he endured a setback, spending 10 weeks on the injured list due to a fractured ribcage. Despite this challenge, Sale's performance in September was remarkable, including four nine-strikeout games in five starts.
As Sale approaches his 37th birthday on March 30, 2026, the Braves are confident in his ability to lead their rotation. In his debut season with the Braves in 2024, Sale dominated the National League, leading with 18 wins, a 2.38 ERA, and an astonishing 225 strikeouts. His success in the American League with the Chicago White Sox and the Boston Red Sox prior to that, further solidifies his status as a top pitcher.
With 145 wins and an ERA of 3.01 in 393 games (312 starts), Sale's career statistics are impressive. He has accumulated 2,579 strikeouts in 2,084 innings, showcasing his consistency and ability to strike out batters. The Braves' decision to extend Sale's contract is a strategic move to maintain their competitive edge in the National League.
